Connect with us

Hi, what are you looking for?

Jewish Business News


Three way takeover battle: Mylan chairman tells investors he would consider buying Teva


TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p

Reuters Exclusive:

Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to sell itself to Israeli rival Teva Pharmaceuticals Industries Ltd (TEVA.TA), but would consider buying that company down the road, Mylan Executive Chairman Robert Coury told investors this week. The company has been steadfast in its refusal to combine with Teva and is instead encouraging shareholders to support its own $34 billion unsolicited offer for over-the-counter drugmaker Perrigo Co Plc (PRGO.N)…

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.


By Olivia Oran and Caryoline Humer



Teva Pharmaceutical Industries Ltd. is in discussions with banks to raise about $25 billion in financing to back its unsolicited bid for Mylan NV, according to people with knowledge of the matter… [READ MORE]

By Dinesh Nair Manuel Baigorri Ed Hammond



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.